![]() |
市场调查报告书
商品编码
1319285
注射泵市场:2019-2029年全球市场规模、份额、趋势分析、机会和预测报告Syringe Pump Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Type ; By Application ; By End User ; By Region |
由于家庭医疗保健服务趋势的不断增长、注射泵技术进步的快速采用以及慢性病患病罹患率的上升,全球注射泵市场正在蓬勃发展。
领先的战略咨询和市场研究公司BlueWeave Consulting最近预计,2022年全球注射泵市场规模将达到218.9亿美元。 BlueWeave 预测,2023 年至 2029 年预测期内,全球注射泵市场规模将以 6.3% 的年复合成长率大幅增长,2029 年达到 333.7 亿美元。全球注射泵市场的主要增长促进因素包括慢性病患病率的增加、人口老龄化的加剧、注射泵设备的技术进步以及对准确和安全的给药系统的需求不断增加。根据全球癌症观察站的数据,2020 年将有大约 19,292,789 例新的癌症诊断。不同性别和年龄组中因癌症死亡的总人数估计约为 9,958,133 人。其中乳腺癌、肺癌、结直肠癌、前列腺癌、胃癌是今年的主流癌症。这些统计数据预计在未来几年将出现显着增长,并将推动注射泵市场的发展。外科手术数量的增加预计也将推动全球注射泵市场的发展。知名市场进入者增加的投资和新产品的推出预计将为预测期内的市场增长创造有利的预测。然而,严格的监管要求和注射泵的高成本预计将限制全球注射泵市场。
该报告的详细分析提供了有关全球注射泵市场的增长潜力、未来趋势和统计数据的信息。它还涵盖了推动市场总规模预测的因素。该报告致力于为决策者提供全球注射泵市场的最新技术趋势以及行业见解,以做出明智的战略决策。它还分析了市场的增长促进因素、挑战和竞争动态。
Global syringe pump market is flourishing because of an increasing trend toward home-based healthcare services, rapid adoption of advancements in syringe pump technology, and rising incidence of chronic diseases.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global syringe pump market size at USD 21.89 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global syringe pump market size to grow at a significant CAGR of 6.3% reaching a value of USD 33.37 billion by 2029. Major growth drivers for the global syringe pump market include an increasing prevalence of chronic diseases, the growing geriatric population, technological advancements in syringe pump devices, and the rising demand for accurate and safe drug delivery systems. According to the Global Cancer Observatory, there were approximately 19,292,789 newly diagnosed cancer cases in 2020. Among individuals of various genders and age groups, the total number of fatalities attributed to cancer was estimated to be around 9,958,133. Notably, breast cancer, lung cancer, colorectal cancer, prostate cancer, and stomach cancer were the prevailing types of cancer during that year. It is expected that these statistics will experience significant growth in the coming years, thereby driving the advancement of the syringe pump market. Also, the expansion in the volume of surgical procedures conducted is expected to facilitate the development of the worldwide syringe pump market. The rise in investments and the introduction of novel products by prominent market participants are projected to generate profitable prospects for market growth during the forecast period. However, stringent regulatory requirements and high cost of syringe pumps are anticipated to restrain the global syringe pump market.
The global syringe pump market refers to the collective market for medical devices that are designed to deliver precise and controlled amounts of fluids or medications to patients. Syringe pumps are commonly used in healthcare settings, including hospitals, clinics, and ambulatory care centers, to administer various therapies, such as intravenous infusions, pain management, anesthesia, neonatal care, and chemotherapy. These devices provide accurate and controlled delivery of medications, ensuring patient safety and therapeutic efficacy. The market encompasses a range of syringe pump types, including traditional syringe pumps used in clinical settings and ambulatory syringe pumps designed for portable use. With advancements in technology, syringe pumps now often incorporate features such as wireless connectivity and integration with electronic health record (EHR) systems to enhance functionality and streamline patient care. The global syringe pump market is driven by factors such as the increasing prevalence of chronic diseases, the growing aging population, demand for safe and accurate drug delivery systems, and technological advancements in syringe pump devices.
COVID-19 pandemic had a dual impact on the global syringe pump market. There was a surge in demand for syringe pumps due to the increased need for accurate medication delivery in critical care settings. The pandemic highlighted the importance of syringe pumps in delivering medications, including vaccines and critical care drugs. Also, syringe pumps and ventilators hold significant importance as essential devices used in intensive care units (ICUs), cardiac care units (CCUs), and emergency rooms. In COVID wards, intravenous (IV) infusion is a common requirement. Infusion pumps play a vital role in monitoring and delivering precise drug doses in hospitals and emergency rooms, enabling healthcare professionals to treat patients while minimizing the risk of infection, as they can be programmed to operate without constant observation. Consequently, the demand for infusion pumps experienced a sharp surge in 2020. Hospitals confronted with the novel coronavirus faced shortages of ventilators, personal protective equipment, and infusion pumps, all of which were crucial for managing the increasing number of COVID-19 patients.
Major players operating in the global syringe pump market include: BD, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Terumo Corporation, Smith's Medical, Moog Inc., B. Braun Melsungen AG, Hospira, Inc., Nipro Corporation, Mindray Medical International Limited, Roche Diagnostics, Zyno Medical, KD Scientific, and NIKKISO CO., LTD. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Syringe Pump Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Syringe Pump Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.